Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Recent & Breaking News (PINL:BIOGY)

Athersys Finishes Enrollment of Phase 2 Study of MultiStem(R) Cell Therapy for Ischemic Stroke

GlobeNewswire December 29, 2014

Dynavax Secures $40 Million Credit Facility With Hercules Technology Growth Capital

Marketwired December 29, 2014

Hanwha Solarone Files Shareholder Circular for Acquisition of Hanwha Q CELLS

PR Newswire December 29, 2014

Frost & Sullivan New Product Innovation Award Conferred on Protein Sciences Corporation for Flublok® Influenza Vaccine

PR Newswire December 29, 2014

Roche receives FDA Emergency Use Authorization for the LightMix® Ebola Zaire rRT-PCR Test

PR Newswire December 29, 2014

Make 2015 an Organic Year

PR Newswire December 29, 2014

Spectrum Pharmaceuticals Files a New Drug Application with the FDA for Captisol-Enabled(TM) (Propylene Glycol-Free) Melphalan

Business Wire December 26, 2014

Scientists create human primordial cells in the lab

UPI December 25, 2014

Novo Nordisk receives FDA approval for Saxenda® (liraglutide [rDNA origin] injection) for chronic weight management

PR Newswire December 24, 2014

FDA Approves Gazyva® (Obinutuzumab) Supplemental Biologics License Application with New Data in Previously Untreated Chronic Lymphocytic Leukemia

Business Wire December 24, 2014

Virginia Beach Organ, Tissue And Cornea Donor To Be Honored On Rose Parade Float

PR Newswire December 24, 2014

Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke

PR Newswire December 24, 2014

Soligenix Announces Closing of Public Offering of Units

PR Newswire December 24, 2014

Corgenix Announces New Grants to Advance Work on Ebola Test Kit

Business Wire December 24, 2014

Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study

PR Newswire December 24, 2014

Cell MedX Corp. (CMXC) Announces Change of Auditors

Marketwired December 24, 2014

PPD and SNBL Announce Japanese Clinical Development Joint Venture and Additional Collaborations

Business Wire December 24, 2014

Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board

PR Newswire December 24, 2014

BioCryst Receives Orphan Drug Designation for BCX4161 for the Treatment of Hereditary Angioedema

GlobeNewswire December 23, 2014

Pieris Pharmaceuticals, Inc. Completes Private Placement, Raises $13.6M

Marketwired December 23, 2014